Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden.
Tine Iskov KoppBénédicte DelcoigneElizabeth V ArkemaRikke Kart JacobsenMelinda MagyariElse Helene IbfeltHenning LochtFinn SellebjergRene Lindholm CordtzDorte V JensenJohan AsklingLene DreyerPublished in: Annals of the rheumatic diseases (2020)
Use of TNFi in AS/PsA, but not in RA, was associated with increased risk of incident neuroinflammatory disease, though the absolute risk was below one in 1000 patients/year.